Stay updated on Dexmedetomidine for Schizophrenia Agitation Clinical Trial
Sign up to get notified when there's something new on the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page.

Latest updates to the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry labeled v3.7.0 was added to the study history, and the previously listed revision v3.6.6 was removed from the history view.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history now shows a new Revision: v3.6.6 and removes Revision: v3.6.5, updating the historical revision trail.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now includes new sections for Contacts/Locations and Study Status on 2026-08-11 and 2026-08-07, expanding how locations and the trial's current status are presented. A deletion on 2026-06-04 removes prior content from the history.SummaryDifference0.5%

- Check65 days agoChange DetectedThe record history now shows a new revision label (v3.6.5) in place of the previous (v3.6.4), indicating a recent update to the page’s version/history metadata rather than changes to trial data. This update affects version tracking but not the study details or outcomes.SummaryDifference0.1%

- Check80 days agoChange DetectedVersion history now shows a new revision labeled v3.6.4, replacing the earlier v3.6.3. This reflects a new build/update of the page rather than changes to the study record content.SummaryDifference0.1%

Stay in the know with updates to Dexmedetomidine for Schizophrenia Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page.